BioMarin Pharmaceutical Inc. (BMRN): Price and Financial Metrics
BioMarin Pharmaceutical Inc. (BMRN)
Today's Latest Price: $107.08 USD
0.43 (-0.40%)
Updated Jun 5 2:27pm
Add BMRN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BMRN Stock Summary
- BMRN has a higher market value than 90.68% of US stocks; more precisely, its current market capitalization is $19,441,770,389.
- With a price/earnings ratio of 170.53, Biomarin Pharmaceutical Inc P/E ratio is greater than that of about 97.18% of stocks in our set with positive earnings.
- Price to trailing twelve month operating cash flow for BMRN is currently 221.09, higher than 98.86% of US stocks with positive operating cash flow.
- Stocks with similar financial metrics, market capitalization, and price volatility to Biomarin Pharmaceutical Inc are DXCM, SNPS, ANET, CDNS, and GDDY.
- BMRN's SEC filings can be seen here. And to visit Biomarin Pharmaceutical Inc's official web site, go to www.biomarin.com.
BMRN Daily Price Range
BMRN 52-Week Price Range
BMRN Stock Price Chart More Charts
BMRN Price/Volume Stats
| Current price | $107.08 | 52-week high | $112.57 |
| Prev. close | $107.51 | 52-week low | $62.88 |
| Day low | $105.79 | Volume | 678,396 |
| Day high | $109.71 | Avg. volume | 1,598,570 |
| 50-day MA | $92.84 | Dividend yield | N/A |
| 200-day MA | $82.74 | Market Cap | 19.36B |
BioMarin Pharmaceutical Inc. (BMRN) Company Bio
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company was founded in 1996 and is based in San Rafael, California.
Loading social stream, please wait...